Insta
Govt Places Order For 66 Crore COVID-19 Vaccine Doses From Serum Institute, Bharat Biotech
Covaxin and Covishield
Amid the ongoing Covid-19 vaccination drive, the Union government has placed an order for 66 crore doses of Serum Institute of India's (SII) Covishield and Bharat Biotech's Covaxin.
The order has been placed for supply of 66 crore Covid-19 vaccine doses at a cost of Rs 14,505.75 crore between August and December.
Further, 22 crore Covid-19 vaccine doses will be made available to the private sector.
Over the next five months, the government aims to get 37.5 crore doses of Covishield and 28.5 crore of Bharat Biotech's Covaxin, reports Economic Times.
The fresh order has been placed at Rs 215.25 per dose for Covishield and Rs 225.75 per dose for Covaxin, inclusive of GST.
The development comes as Centre, in an affidavit filed on 25 June, told the Supreme Court that India will have access to 1.35 Covid-19 vaccine doses through December, enough to cover the eligible adult population of the country.
The government's estimate includes 50 crore doses of Covishield, 40 crore of Covaxin, 30 crore of Biological E's vaccine, 5 crore of Zydus' jab and 10 crore Russian Sputnik V jabs.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
